With different generic rivals, Lipitor’s sales halved
Miller Tabak analyst Les Funtleyder says the drip arrived the run to of Lipitor prescriptions crammed is not what remarkable what he anticipated.Lipitor lost U.S. patent protection on Nov. 30, and two generic versions estimate all but one-third a smaller amount are at present existing.
.